Advances in Pharmacoepidemiology and Drug Safety

Riju Ray

Riju Ray, PhD
Senior Manager, Clinical Development, Immunotherapeutics
GlaxoSmithKline Biologicals, Belgium

Biography

Riju Ray is a MD/PhD clinical researcher with primary experience in pharmacology, neuroscience, psychiatry and oncology. At present he is working as a Senior Manager, Late Clinical Development Immunotherapeutics, Rixensart, Belgium GSK Biologicals.He worked a s a Assistant Professor (Research) [9/10 - 4/11], at Department of Psychiatry, University of Pennsylvania Philadelphia, USA. His Doctorate of Philosophy (Ph.D.) from [Department of Pharmacology] from University of Pennsylvania, Philadelphia, USA 2003 – 2007. Dissertation: Effects of Atomoxetine on nicotine abstinence symptoms. He received his degree in medicine M.B.B.S. (MD equivalent) from University of Delhi, New Delhi, India 1997-2002.

Research Interest

Translational medicine, clinical trials, human medication laboratory studies, biomarker studies, proof of concept (POC) studies, pharmacogenetics, molecular biology and pre-clinical research.